Holders — by stockHoldings — by fund
First Light Asset Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001600004
$1.69B
disclosed book value
32
positions
9.3%
largest position share
Positions, as of 2026-09-30
top 32 of 32 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | AXGNAXOGEN INC | 3.7M | $156.7M | 9.3% |
| 2 | NEONEOGENOMICS INC | 8.5M | $155.3M | 9.2% |
| 3 | SIBNSI-BONE INC | 7.7M | $144.5M | 8.6% |
| 4 | AMLXAMYLYX PHARMACEUTICALS INC | 4.0M | $116.0M | 6.9% |
| 5 | PVLAPALVELLA THERAPEUTICS INC | 734,086 | $101.3M | 6% |
| 6 | EWTXEDGEWISE THERAPEUTICS INC | 2.5M | $100.8M | 6% |
| 7 | TWSTTWIST BIOSCIENCE CORPORATION | 430,348 | $83.2M | 4.9% |
| 8 | MASS908 DEVICES INC | 6.6M | $82.0M | 4.9% |
| 9 | GHGUARDANT HEALTH | 437,882 | $78.1M | 4.6% |
| 10 | VERAVERA THERAPEUTICS INC | 2.0M | $63.3M | 3.8% |
| 11 | WGSGENEDX HOLDINGS CORP | 786,901 | $56.9M | 3.4% |
| 12 | NPCENEUROPACE INC | 4.0M | $54.8M | 3.2% |
| 13 | TNDMTANDEM DIABETES CARE INC | 3.3M | $53.0M | 3.1% |
| 14 | ELVNENLIVEN THERAPEUTICS INC | 1.0M | $46.7M | 2.8% |
| 15 | SEPNSEPTERNA INC | 1.2M | $45.6M | 2.7% |
| 16 | INSPINSPIRE MEDICAL SYSTEMS INC | 599,653 | $41.6M | 2.5% |
| 17 | SLPSIMULATIONS PLUS INC | 2.2M | $41.3M | 2.4% |
| 18 | ATRCATRICURE INC | 662,134 | $37.2M | 2.2% |
| 19 | TRVITREVI THERAPEUTICS INC | 2.4M | $34.2M | 2% |
| 20 | TLSITRISALUS LIFE SCIENCES INC | 7.4M | $32.0M | 1.9% |
| 21 | IRTCIRHYTHM TECHNOLOGIES | 214,713 | $24.4M | 1.4% |
| 22 | BFLYBUTTERFLY NETWORK INC | 2.6M | $23.4M | 1.4% |
| 23 | HCATHEALTH CATALYST INC | 12.7M | $22.1M | 1.3% |
| 24 | BBNXBETA BIONICS INC | 1.1M | $21.1M | 1.2% |
| 25 | ANABANAPTYS BIO INC | 328,523 | $16.5M | 1% |
| 26 | TECXTECTONIC THERAPEUTICS INC | 495,950 | $11.6M | 0.7% |
| 27 | BSXBOSTON SCIENTIFIC CORP | 237,744 | $10.4M | 0.6% |
| 28 | PCVXVAXCYTE INC | 142,820 | $8.1M | 0.5% |
| 29 | KRMDKORU MEDICAL SYSTEMS INC | 2.7M | $8.0M | 0.5% |
| 30 | RYTMRHYTHM PHARMACEUTICALS INC | 83,467 | $7.9M | 0.5% |
| 31 | ESTAESTABLISHMENT LABS HOLDINGS | 99,219 | $6.4M | 0.4% |
| 32 | BILSPDR BLOOMBERG BARCLAYS 1-3 MONTH T-BILL ETF | 33,181 | $3.0M | 0.2% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.